We provide comprehensive medical care for patients with malignant solid tumors. In patients who are suspected of having cancer, we make a definite diagnosis of the disease, which is critical ensure best treatment. Individual cases are discussed by medical oncologists, radiation oncologists, surgeons, specialized staff for palliative care, pathologists, and specialists of other fields, if necessary, to provide the most effective treatment and give advanced medical care. Systemic drug therapy is provided mainly at the outpatient chemotherapy center as well as on an inpatient basis. Recent advances in supportive care enable patients to receive chemotherapy as needed. In addition, we are actively involved in clinical research and the development of new therapies.
Any types of malignant solid tumors for which systemic drug therapy is required. These include metastatic diseases treated with systemic chemotherapy, hormonal therapy, molecular targeted therapy, and immune checkpoint therapy. For locally advanced diseases, chemoradiotherapy, and adjuvant chemotherapy after surgery are provided in cooperation with other departments.
|Associate Professor||Makoto Arai|